Published in J Biol Chem on December 25, 1985
Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest (1996) 1.69
Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci U S A (1988) 1.51
Cultured human endothelial cells stimulated with cytokines or endotoxin produce an inhibitor of leukocyte adhesion. J Clin Invest (1988) 1.19
Cellular oxidative modification of low density lipoprotein does not require lipoxygenases. Proc Natl Acad Sci U S A (1992) 1.03
Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs. Adv Nutr (2015) 0.91
Lysophospholipase A2 activity in guinea-pig heart microsomal fractions displaying high activities with 2-acylglycerophosphocholines with linoleic and arachidonic acids. Biochem J (1989) 0.89
Intravascular filarial parasites inhibit platelet aggregation. Role of parasite-derived prostanoids. J Clin Invest (1992) 0.88
Immunohistochemical detection of 13(R)-hydroxyoctadecadienoic acid in atherosclerotic plaques of human carotid arteries using a novel specific antibody. Acta Histochem Cytochem (2009) 0.83
Metabolic interactions between eicosanoids in blood and vascular cells. Biochem J (1989) 0.79
Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro. Br J Pharmacol (1991) 0.78
Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study. J Am Heart Assoc (2015) 0.77
The vasodilatation induced by hydroperoxy metabolites of arachidonic acid in the rat mesenteric and pulmonary circulation. Br J Pharmacol (1987) 0.77
Apoptosis of Endothelial Cells by 13-HPODE Contributes to Impairment of Endothelial Barrier Integrity. Mediators Inflamm (2016) 0.75
Ligand binding to integrins. J Biol Chem (2000) 4.94
Policy interventions that attract nurses to rural areas: a multicountry discrete choice experiment. Bull World Health Organ (2010) 2.17
Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J (2000) 1.89
Haemodialysis related osteomalacia: a staining method to demonstrate aluminium. J Clin Pathol (1981) 1.67
Adhesion molecules and their role in cancer metastasis. Cell Biophys (1995) 1.57
Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid. J Biol Chem (1995) 1.45
Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity. J Clin Invest (1978) 1.43
A 69-year-old smoker with mediastinal and hilar lymphadenopathy. Thorax (2010) 1.42
Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfate. J Cardiothorac Vasc Anesth (1995) 1.38
Studies on the interaction between GP-18-0-deficient neutrophils and vascular endothelium. Blood (1982) 1.34
A simple and efficient method for platelet isolation from their plasma. Thromb Res (1980) 1.26
Ligand and cation binding are dual functions of a discrete segment of the integrin beta 3 subunit: cation displacement is involved in ligand binding. Cell (1994) 1.26
Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem J (1989) 1.25
Arachidonic acid metabolism and the adhesion of human polymorphonuclear leukocytes to cultured vascular endothelial cells. Blood (1983) 1.23
Interactions of platelets and leukocytes with vascular endothelium: in vitro studies. Ann N Y Acad Sci (1982) 1.18
Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine. J Lipid Res (1999) 1.15
Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med (2005) 1.15
The phospholipid and fatty acid composition of human platelet surface and intracellular membranes isolated by high voltage free flow electrophoresis. J Biol Chem (1982) 1.12
Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. Am J Clin Nutr (1996) 1.09
Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes. FEBS Lett (1981) 1.08
Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant? Thromb Haemost (1993) 1.07
Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain. Am J Physiol (1994) 1.06
The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin. Biochem J (1987) 1.05
Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic Biol Med (1998) 1.05
Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation. Biochem Pharmacol (1999) 1.05
Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells. J Lipid Res (1997) 1.04
The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site. J Biol Chem (2000) 1.04
Unsaturated fatty acids esterified in 2-acyl-l-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form. J Neurochem (1992) 1.03
Platelets mediate the action of diethylcarbamazine on microfilariae. Nature (1987) 1.02
Herpes simplex virus from the lower respiratory tract in adult respiratory distress syndrome. Am Rev Respir Dis (1982) 1.02
Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Arch Biochem Biophys (1999) 1.01
Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation. FEBS Lett (2009) 1.01
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res (1980) 0.99
Interleukin-1 increases tumor cell adhesion to endothelial cells through an RGD dependent mechanism: in vitro and in vivo studies. Clin Exp Metastasis (1990) 0.98
Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma. Biochem Biophys Res Commun (2005) 0.98
The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin. Blood (1985) 0.98
Interconvertible kinetic and physical forms of human erythrocyte pyruvate kinase. J Biol Chem (1971) 0.96
Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem Pharmacol (1994) 0.95
Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites. Prostaglandins Leukot Essent Fatty Acids (2006) 0.95
Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med (1976) 0.95
The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell. FEBS Lett (2007) 0.95
Sustained thrombolysis with DNA-recombinant tissue type plasminogen activator in rabbits. Blood (1985) 0.92
Endothelial cells produce a lipoxygenase derived chemo-repellent which influences platelet/endothelial cell interactions--effect of aspirin and salicylate. Thromb Haemost (1985) 0.92
Walker carcinosarcoma cells damage endothelial cells by the generation of reactive oxygen species. Am J Pathol (1989) 0.92
Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products. Free Radic Biol Med (1998) 0.92
Cigarette smoking and platelet aggregation. Can Med Assoc J (1966) 0.91
Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids. Biochem Biophys Res Commun (1983) 0.91
Protective effect of docosahexaenoic acid against hydrogen peroxide-induced oxidative stress in human lymphocytes. Biochem Pharmacol (1999) 0.91
12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets. Thromb Res (1991) 0.90
Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels. J Neurochem (1996) 0.90
Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa. Biochem J (1989) 0.90
Metabolic fate of an oral tracer dose of [13C]docosahexaenoic acid triglycerides in the rat. Am J Physiol (1996) 0.89
Peptide ligands can bind to distinct sites in integrin alphaIIbbeta3 and elicit different functional responses. J Biol Chem (1999) 0.89
Aspirin inhibits platelet function independent of the acetylation of cyclo-oxygenase. Thromb Res (1982) 0.89
LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets. Diabetologia (2011) 0.89
Catalysis of thrombin inhibition provides an index for estimating the antithrombotic potential of glycosaminoglycans in rabbits. Thromb Haemost (1987) 0.89
Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: role of vessel wall 13-HODE synthesis and integrin expression. Clin Exp Metastasis (1993) 0.89
Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res (1984) 0.89
Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids. Adv Exp Med Biol (1985) 0.88
Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Mol Pharmacol (1993) 0.88
A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation. Thromb Res (1984) 0.88
Neutralization of enoxaparine-induced bleeding by protamine sulfate. Thromb Haemost (1990) 0.88
Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids. Prostaglandins Leukot Essent Fatty Acids (2002) 0.87
Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo. Ann N Y Acad Sci (1989) 0.87
Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. J Mol Cell Cardiol (1996) 0.87
The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects. Thromb Res (1983) 0.87
The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivo. Thromb Res (1978) 0.87
The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate. Br J Haematol (1985) 0.87
Mitochondrial H2O2 production is reduced with acute and chronic eccentric exercise in rat skeletal muscle. Antioxid Redox Signal (2006) 0.87
Stable isotope tracer and gas-chromatography combustion isotope ratio mass spectrometry to study the in vivo compartmental metabolism of docosahexaenoic acid. Anal Biochem (1994) 0.87
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. Thromb Res (1988) 0.86
Cyclic AMP regulation of endothelial cell triacylglycerol turnover, 13-hydroxyoctadecadienoic acid (13-HODE) synthesis and endothelial cell thrombogenicity. Biochim Biophys Acta (1990) 0.86
Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother (2013) 0.86
Chemotherapy enhances endothelial cell reactivity to platelets. Clin Exp Metastasis (1990) 0.86
Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides. Br J Haematol (1986) 0.86
Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells. Mol Biol Cell (1999) 0.86
Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation. Biochem J (1997) 0.86
Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab (1997) 0.86
The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis (1999) 0.86
DHA metabolism: targeting the brain and lipoxygenation. Mol Neurobiol (2010) 0.86
Gas chromatographic-mass spectrometric measurement of 15-deoxy-delta(12,14)-prostaglandin J(2), the peroxisome proliferator-activated receptor gamma ligand, in urine. Clin Chem (2001) 0.86
Interactions between prostaglandin precursors during their oxygenation by human platelets. Biochim Biophys Acta (1982) 0.86
Functional lipidomics of oxidized products from polyunsaturated fatty acids. Chem Phys Lipids (2011) 0.86
Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid. J Neurochem (1999) 0.86
Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients. Diabetologia (2003) 0.85
Specific markers of lipid peroxidation issued from n-3 and n-6 fatty acids. Biochem Soc Trans (2004) 0.85
Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate. Biochem J (1987) 0.85
Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapy. Eur J Clin Invest (1992) 0.85